Insider buying last 90 days
No open-market insider purchases were filed for ICL in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every ICL insider filing, plotted on the chart in Gekko.Open ICL in Gekko
Gekko Brief
AI summaryThis week's coverage of ICL centers on its dividend profile, with several pieces highlighting the company's above-average yield in the fertilizers industry and its history of dividend growth as central to the investment case, alongside a note on the stock's decline of 6.13% since January 1, 2026. A separate bond profile piece detailed the ICL.B7 issue's coupon and redemption terms.
ICL closed at $5.02, down 2.3%, with the close sitting between its 50-day and 200-day averages, both at $5.44, reflecting a mixed trend. The stock's one-month return stands at -11.5%, its six-month return at -3.5%, and its one-year return at -16.5%, while the 52-week range spans $4.76 to $6.97. The GekkoIndex reads 69.8, placing ICL in the Accumulation zone, up 4.6 over five days. Price sits 8.6% below Gekko Fair Value of $5.49.
Over the next 20 trading days, ICL's earnings report is scheduled for 11 November 2026, 43 days out, before the open, placing it outside a typical holding window. No insider, Congress, or unusual options activity appears in the recent windows. Seasonally, this calendar point has produced an average 20-day return of 2.2% across 5 years, rising in 3 of them. Analyst consensus from 3 firms rates ICL a hold, with a consensus target of $5.81, implying 15.7% upside from current levels.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
ICL price vs fair value
Close $5.02200-day averageGekko Fair Value $5.49
ICL quick facts
- Market cap
- $6.48B
- P/E ratio
- 21.4
- Forward P/E
- 55.6
- EPS, TTM
- $0.24
- Revenue, TTM
- $7.71B
- Profit margin
- 4%
- Dividend yield
- 4.00%
- Beta
- 1.00
- Volume
- 888,937 avg 1.25M
- 1-year return
- −16.5%
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±7.1%
- 50-day average
- $5.44
- 200-day average
- $5.44
- Next earnings
- Nov 11 before open
- Shares outstanding
- 1.29B
ICL swing-trade checklist
ICL scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
- Trendmixed
Averages disagree
Close $5.02 sits between the 50-day ($5.44) and 200-day ($5.44) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
69.8, Accumulation
Reading 69.8 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
8.6% below
Price is 8.6% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 43 days
Next report Nov 11, 2026, 43 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+2.2% on average
From this point in the calendar, the next 20 trading days averaged +2.2% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
ICL stock chart and price history
ICL closed at $5.02 on Sep 28, 2026, −16.5% over the past year, inside a 52-week range of $4.76 to $6.97.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −11.5%
- 3 months
- +0.2%
- 6 months
- −3.5%
- 1 year
- −16.5%
The full ICL chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ICL in Gekko
Follow ICL through every session
Put ICL on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track ICL in GekkoFree for 7 days. No credit card required.
About ICL
ICL is a global producer of minerals and chemicals, working across four business units. It extracts bromine from a byproduct of potash production and turns it into bromine-based compounds, alongside potash, salt, magnesium chloride and magnesia products, plus phosphorus-based flame retardants. It also draws potash from the Dead Sea and mines and produces potash and salt more broadly, making it known for its mineral extraction and processing activities.
Beyond raw extraction, ICL converts phosphate commodities into fertilizers, sulphuric acid, and phosphoric acid used across oral hygiene, cleaning, paints and coatings, water treatment, asphalt, construction and metal treatment. It also makes functional food ingredients and phosphate additives for processed meat, poultry, seafood, dairy, beverages and baked goods, as well as milk and whey proteins for the food ingredients industry. Its Innovative Ag Solutions unit develops nitrogen, potash and phosphate fertilizers, including water-soluble, liquid, soluble and controlled-release forms, sold worldwide through marketing firms, agents and distributors.
The company began as Israel Chemicals Ltd, founded in 1968, and took its present name in May 2020. It is headquartered in Tel Aviv, Israel, and its shares trade on the NYSE under the ticker ICL.
- Listed
- NYSE
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Website
- icl-group.com
ICL GekkoIndex: the smart money zone
ICL’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 69.8, in the Accumulation zone, up 4.6 points over five sessions.
69.8Accumulation
Up 4.6 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 46 | +1.3% | +3.2% | ||
| Accumulation (current zone) | 193 | +0.6% | +2.0% | ||
| Neutral | 389 | −0.1% | +0.3% | ||
| Distribution | 37 | +1.3% | −0.3% | ||
| Selling | 7 | Too few readings yet | |||
Average ICL share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the ICL price, zone by zone.Track ICL in Gekko
Is ICL stock overvalued? Gekko Fair Value
ICL trades 8.6% below Gekko Fair Value of $5.49, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what ICL shares are worth, recalculated every trading day.
$5.49
Gekko Fair Value, Sep 29, 2026
8.6% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open ICL in Gekko
ICL insider and Congress trading
No open-market insider purchases were filed for ICL, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in ICL were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for ICL, plotted on the chart in Gekko.Open ICL in Gekko
Hedge funds and billionaires quarter ended Jun 30
0of the funds Gekko tracks hold ICL.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
ICL earnings: next date and track record
ICL reports on Nov 11, 2026, before the open (43 days away), and beat the EPS estimate in 4 of its last 8 reports.
Next earnings report
Nov 11, 2026
Expected before the open, 43 days away
- EPS estimate
- $0.12
- Revenue estimate
- $2.13B
4 of 8reports beat the EPS estimate
±2.8%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Feb 12, 2026 AI summary
- What they said
- ICL reported a solid finish to 2025, achieving its annual target of $1 billion of specialty-driven EBITDA. Management highlighted strategic progress including acquisitions (Bartek Ingredients and Lavie Bio) to expand specialty food and growing solutions, a binding agreement with the State of Israel securing compensation for Dead Sea concession assets and bromine supply through at least 2035, and continued focus on maximizing core potash operations. Operational improvements in potash production in the Dead Sea and Spain were noted. Management outlined a refined strategy prioritizing specialty crop nutrition and specialty food solutions, continued disciplined capital allocation (pausing/terminating lower-synergy projects such as LFP battery projects and shelving Boulby), and plans for further M&A and a cost transformation program. Macro and segment-level headwinds include elevated sulfur prices (major raw material for phosphate products), a strong shekel versus the dollar increasing local costs, mixed agricultural fundamentals (Brazil challenging, China bromine demand uncertain) and credit constraints in Brazil for farmers and distributors. Management’s Q&A provided color on drivers and sensitivities: potash volumes/prices and bromine as upside, sulfur costs and shekel strength as downside, and shekel sensitivity (~$10 million EBITDA impact per 1% move) with roughly 50-60% hedging.
- Guidance
- Management guided 2026 to be largely 'very similar' or flattish compared with 2025 at the midpoint. They flagged upside scenarios (higher potash volumes/prices and potential bromine price recovery post-Chinese New Year) and downside risks (sustained high sulfur costs and continued shekel strengthening). Management provided a USD/ILS assumption range seen in the market of roughly 315-320+ and stated their hedged exposure is around 50-60%.
- Risks flagged
- Elevated sulfur prices (major input for phosphate products), stronger shekel versus the U.S. dollar (increases Israel-based operating costs), credit constraints and farmer affordability issues in Brazil (supplier financing risk and distribution pressure), uncertainty in Chinese bromine demand post-New Year, and broader macro/commodity volatility. Management also cited battery market structural changes that reduced the attractiveness of certain downstream investments.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Feb 12, 2026 | $0.09 est $0.10 | $1.70B est $1.77B | −0.3% |
| Nov 10, 2025 | $0.10 est $0.11 | $1.85B est $1.95B | +0.4% |
| Aug 6, 2025 | $0.09 est $0.08 | $1.83B est $1.83B | +2.8% |
| May 19, 2025 | $0.09 est $0.08 | $1.77B est $1.82B | −2.5% |
| Feb 26, 2025 | $0.08 est $0.09 | $1.60B est $1.71B | −4.7% |
| Nov 11, 2024 | $0.11 est $0.08 | $1.75B est $1.65B | +3.4% |
| Aug 14, 2024 | $0.10 est $0.09 | $1.75B est $1.76B | +7.3% |
| May 9, 2024 | $0.09 est $0.09 | $1.72B est $1.75B | −1.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
ICL stock forecast and analyst price targets
Analysts’ average 12-month price target for ICL is $5.81, +15.7% from the last close, from 3 firms rating the stock in the last 90 days.
$5.81consensus 12-month target, +15.7% from the last close
Now $5.02Avg $5.81
Low $5.75High $6
Each firm’s latest rating in the last 90 days: 3 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 11 | Barclays | $6 | +19.5% |
| Aug 10 | Morgan Stanley | $5.75 | +14.5% |
| Aug 6 | BMO Capital | $6 | +19.5% |
| Aug 6 | Barclays | $6 | +19.5% |
| Jul 27 | Barclays | $6 | +19.5% |
+2.0%average 20-day move after past Accumulation readings
+2.2%average move over the next 20 trading days in the last 5 years
±2.4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
ICL seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, ICL averaged +2.2% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.5% | 3 of 5 |
| Next 10 trading days | +2.1% | 3 of 5 |
| Next 15 trading days | −0.2% | 2 of 5 |
| Next 20 trading days | +2.2% | 3 of 5 |
| Next 30 trading days | −1.2% | 2 of 5 |
For scale, ICL’s typical 20-trading-day move in either direction is about 7.1%.
ICL market cap and key statistics
ICL’s market cap is $6.48B, with a P/E ratio of 21.4 and revenue of $7.71B over the last twelve months.
Valuation
- Market cap
- $6.48B
- P/E ratio
- 21.4
- Forward P/E
- 55.6
- EPS, TTM
- $0.24
- Gekko Fair Value
- $5.49
Trading
- Volume
- 888,937
- Avg volume, 20 days
- 1.25M
- 52-week high
- $6.97
- 52-week low
- $4.76
- Shares outstanding
- 1.29B
Financials
- Revenue, TTM
- $7.71B
- Profit margin
- 4%
- Return on equity
- 5.6%
- Quarterly earnings growth, YoY
- +51.6%
Risk and income
- Beta
- 1.00
- Typical daily move
- ±2.4%
- Typical 20-day move
- ±7.1%
- Dividend yield
- 4.00%
ICL stock news this week
Coverage of ICL this week reads neutral: 1 positive, 2 neutral and 0 negative headlines.
- ICL.B7 Bond Profile: Coupon and RedemptionTradingView, Sep 25
- ICL Group stock holds its dividend case as 2026 data emergeAD HOC NEWS, Sep 22
- Dividend Strength Might Change The Case For Investing In ICL Group Stock (ICL)Simply Wall Street, Sep 22
- Why ICL Group (ICL) is a Great Dividend Stock Right NowZacks Investment Research, Sep 21
ICL peers
ICL’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| NTRNutrien | Accumulation | 4.7% above |
| CFCF Industries | Accumulation | 35.4% below |
| MOSMosaic | Accumulation | 18.1% below |
| SMGScotts Miracle-Gro | Buying | 28.3% below |
| UANCVR Partners | Accumulation | 36.7% below |
| ODCOil-Dri Corporation Of America | Neutral | 3.4% below |
A peer links to its own page where one exists.
ICL stock FAQ
What is ICL’s market cap?
ICL’s market cap is $6.48B at the Sep 28, 2026 close of $5.02, with 1.29B shares outstanding. The shares trade on a P/E ratio of 21.4.
What is the ICL stock forecast?
The consensus analyst 12-month price target for ICL is $5.81, +15.7% from the last close. Of the 3 firms that rated the stock in the last 90 days, 0 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is ICL stock overvalued or undervalued?
On Gekko’s estimate ICL is undervalued: the Sep 28, 2026 close of $5.02 is 8.6% below Gekko Fair Value of $5.49. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does ICL report earnings next?
ICL is expected to report on Nov 11, 2026, before the market opens (43 days away). Analysts expect earnings of $0.12 per share on revenue of $2.13B. ICL beat the earnings estimate in 4 of its last 8 reports, moving 2.8% on average across the report.
What is ICL’s 52-week high and low?
ICL’s 52-week high is $6.97 and its 52-week low is $4.76; it closed at $5.02 on Sep 28, 2026, −16.5% over the past year. Over the last five years the shares peaked at $12.96 on Apr 14, 2022.
Is ICL stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See ICL the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.